Showing results 2 to 2 of 2
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy Proceeding/Conference:Journal of Hepatology | 2020 | 49 |